TrialJournal of clinical psychopharmacology

Navacaprant, a Novel and Highly Selective Kappa Opioid Receptor Antagonist, in Adults With Major Depressive Disorder: A Randomized, Double-Blind Phase 2 Clinical Trial.

Sanjay J Mathew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.